Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,307 | 2,626 | 5,380 | 7,241 | 900 |
| Other current assets | 0 | 0 | 0 | 0 | 35 |
| TOTAL | $2,516 | $3,955 | $6,189 | $7,894 | $1,390 |
| Non-Current Assets | |||||
| PPE Net | 28 | 31 | 23 | 18 | 8 |
| Other Non-Current Assets | 441 | 0 | 0 | 0 | 0 |
| TOTAL | $469 | $31 | $23 | $18 | $8 |
| Total Assets | $2,985 | $3,986 | $6,211 | $7,912 | $1,398 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 300 |
| Accounts payable and accrued liabilities | 250 | 151 | 191 | 290 | 288 |
| Accrued Expenses | 261 | 111 | 145 | 22 | 46 |
| Other current liabilities | N/A | N/A | N/A | N/A | 763 |
| TOTAL | $511 | $261 | $336 | $311 | $1,398 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $511 | $261 | $336 | $311 | $1,398 |
| Shareholders' Equity | |||||
| Common Shares | 17 | 17 | 17 | 17 | 14 |
| Retained earnings | -17,941 | -15,930 | -13,457 | -11,489 | -8,961 |
| TOTAL | $2,475 | $3,725 | $5,875 | $7,601 | $0 |
| Total Liabilities And Equity | $2,985 | $3,986 | $6,211 | $7,912 | $1,398 |